How many employees does Maravai LifeSciences Holdings, Inc. have?

Maravai LifeSciences Holdings, Inc. reported 435 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is down 23.7% from a year earlier.

What is Maravai LifeSciences Holdings, Inc.'s revenue per employee?

Maravai LifeSciences Holdings, Inc. brought in $186M of revenue in fiscal Dec 2025, which is $427K per employee. That ranks 59 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Maravai LifeSciences Holdings, Inc. employees and revenue per employee

MRVI · Biotechnology · $2.06B market cap

Maravai LifeSciences Holdings, Inc. had 435 employees at the end of fiscal Dec 2025, down 23.7% from a year earlier. Revenue for the year was $186M, down 28.3% from a year earlier, or $427K per employee. Revenue fell, and headcount fell or held flat with it.

Employees

435

-23.7% YoY

Revenue

$186M

-28.3% YoY

Revenue / employee

$427K

Peer median $459K

Rank in industry

59 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020

Hover a year for the numbers.

MRVI employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	435	$186M	$427K	-23.7%	-28.3%
Dec 2024	570	$259M	$455K	-12.3%	-10.3%
Dec 2023	650	$289M	$445K	+6.6%	-67.3%
Dec 2022	610	$883M	$1.45M	+29.8%	+10.5%
Dec 2021	470	$799M	$1.70M	+14.6%	+181.3%
Dec 2020	410	$284M	$693K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Maravai LifeSciences Holdings, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
IDYA IDEAYA Biosciences, Inc.	145	$219M	$1.51M	Efficient growth
MAZE Maze Therapeutics, Inc.	125	$168M	$1.34M	—
STOK Stoke Therapeutics, Inc.	170	$184M	$1.08M	Efficient growth
SNDX Syndax Pharmaceuticals, Inc.	298	$172M	$578K	Efficient growth
PHAT Phathom Pharmaceuticals, Inc.	371	$175M	$472K	Leaner
RGNX REGENXBIO Inc.	371	$170M	$459K	Efficient growth
RYTM Rhythm Pharmaceuticals, Inc.	414	$190M	$458K	Hiring ahead
MRVI Maravai LifeSciences Holdings, Inc.	435	$186M	$427K	Contracting
DNA Ginkgo Bioworks Holdings, Inc.	485	$170M	$351K	Contracting

Every Healthcare company

Questions about Maravai LifeSciences Holdings, Inc.

How many employees does Maravai LifeSciences Holdings, Inc. have?: Maravai LifeSciences Holdings, Inc. reported 435 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is down 23.7% from a year earlier.
What is Maravai LifeSciences Holdings, Inc.'s revenue per employee?: Maravai LifeSciences Holdings, Inc. brought in $186M of revenue in fiscal Dec 2025, which is $427K per employee. That ranks 59 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare MRVI with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Maravai LifeSciences Holdings, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell MRVI.